Manorama Industries Limited has released the transcript of its Q4 and FY 2025-2026 Earnings Conference Call held on May 12, 2026. The company reported a strong financial performance for the full year, with stand-alone revenue reaching INR 1,358 crores, a growth of 76.1% year-on-year. Profit after tax (PAT) for the year stood at INR 233.2 crores, translating to a PAT margin of 17.2%.

Financial Highlights for FY 2025-2026

The management attributed the exceptional performance to resilience in the integrated value chain and sustained global demand for specialty fats. Key operational metrics improved significantly, with EBITDA rising to INR 367.7 crores and an EBITDA margin of 27.1%. The working capital cycle improved to 125 days in FY 2026 from 151 days in the previous year, while net cash flow from operating activities was INR 259.4 crores.

Q4 Performance and Strategic Outlook

For the fourth quarter, stand-alone revenue was INR 382.3 crore, with a PAT of INR 59.5 crores and a margin of 15.6%. The company noted that its solvent fractionation plant 2 capacity increased by 30% to 32,500 tons per annum following debottlenecking initiatives. Looking ahead, Manorama Industries plans a strategic capital expenditure of approximately INR 460 crores over the next two to three years. This includes setting up a new solvent fractionation facility, expanding refining capabilities, and commissioning raw material processing units in Burkina Faso, West Africa, to support backward integration.

Accessing the Transcript

The full transcript of the earnings conference call has been uploaded to the company's official website. Investors can access the document under the Investors section, specifically within Company Announcements and Analyst Meet. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Manorama Industries held its Board of Directors meeting on Monday, May 11, 2026, commencing at 4:00 P.M. (IST) and concluding at 6:18 P.M. (IST). The company subsequently filed a revised press release on its audited financial results (both standalone and consolidated) for the quarter and financial year ended March 31, 2026, noting that an incorrect consolidated audited financial results had been inadvertently attached in the earlier filing. The revised submission, signed by Company Secretary and Compliance Officer Deepak Sharma, contains the corrected standalone and consolidated audited financial results. The Audit Report issued by statutory auditors M/s. Singhi & Co., Chartered Accountants (Firm Registration No: 302049E) carries an unmodified (unqualified) opinion. The company, amongst one of the pioneers in the manufacturing of Cocoa Butter Equivalent (CBE), specialty fats & butters and exotic products, delivered FY26 revenue growth of 76.1% YoY to INR 13,577 Mn, EBITDA growth of 92.5% YoY to INR 3,677 Mn, and PAT growth of 108.1% YoY to INR 2,332 Mn on a standalone basis. Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 were subsequently published in the following newspapers on May 13, 2026: Business Standard (English) and Loksatta (Marathi).

Standalone Financial Performance

Manorama Industries delivered a strong standalone performance for FY26, with revenue from operations and net profit both registering significant growth compared to the previous year. The following table summarises the key standalone financial metrics:

On a standalone basis, the paid-up equity share capital stood at ₹1,194.17 lacs (face value of ₹2/- each), and reserves excluding revaluation reserves were ₹68,291.95 lacs as at March 31, 2026.

Consolidated Financial Performance

The revised consolidated results encompass Manorama Industries and its nine subsidiaries spanning Nigeria, Dubai, Togo, Brazil, Ghana, Burkina Faso, Ivory Coast, and Benin. The following table presents the corrected consolidated financial metrics:

Consolidated reserves excluding revaluation reserves stood at ₹67,018.72 lacs, and total consolidated assets were ₹1,19,950.73 lacs as at March 31, 2026. Total consolidated equity stood at ₹68,212.89 lacs. For FY26, the Domestic to Export Revenue Mix stood at 43:57, reflecting diversified market presence.

Key Performance Highlights

The following table presents the key standalone performance metrics including EBITDA, margins, and QoQ comparisons:

The growth in revenue was fuelled by a favourable product mix of value-added products, complemented by higher utilization from the enhanced fractionation capacity. EBITDA improvement benefitted from cost control measures and operational optimisation. During the quarter, adverse currency fluctuations resulted in the company recognising a mark-to-market (MTM) provision of ₹17.05 crore on forward contracts entered into in accordance with its foreign exchange hedging policy. The cumulative MTM provision for the financial year stands at ₹23.30 crore. The company also recorded foreign exchange income of ₹9.47 crore during the quarter, resulting in a net foreign exchange loss for the quarter of ₹7.58 crore.

Dividend and Key Board Decisions

The Board approved and recommended a final dividend of ₹0.80 (Eighty Paisa only) per equity share of ₹2/- face value, representing 40% of face value, for FY26. Subject to member approval at the ensuing Annual General Meeting (AGM), the dividend will be paid within 30 days from the date of the AGM. In addition to the financial results and dividend, the Board also resolved the following key matters:

The financial support to Taang Kaam Industries SA — a wholly owned subsidiary of Manorama Industries incorporated in Burkina Faso — is intended to support the establishment of a processing factory in Burkina Faso. The support will be extended in one or more tranches, subject to applicable laws and required approvals.

Balance Sheet and Cash Flow Highlights

On a standalone basis, total assets stood at ₹1,20,050.14 lacs as at March 31, 2026, compared to ₹98,502.21 lacs in the prior year. Total equity increased to ₹69,486.12 lacs from ₹46,191.59 lacs. Net cash flow from operating activities was ₹25,936.87 lacs for FY26, compared to a net outflow of ₹5,873.14 lacs in FY25. Cash and cash equivalents at the end of the year stood at ₹743.08 lacs on a standalone basis and ₹994.05 lacs on a consolidated basis. The company's working capital cycle improved to approximately 125 days in FY26. The company achieved a milestone whereby its annual Cash Profit (PAT + Depreciation) of ₹258.77 Crore exceeded its Gross Block (Land + Building + Plant & Machinery) of ₹250.85 Crore, reflecting strong capital efficiency. The company's only reportable business segment is the manufacturing of exotic seed-based fats and butters, including Cocoa Butter Equivalent (CBE), as per IND AS-108.

Management Commentary

Commenting on the performance, Chairman and Managing Director Mr. Ashish Saraf said:

"Manorama Industries has once again delivered a sustainable performance during FY26. The Company achieved revenues of INR 1,358 Crores, reflecting a year-on-year growth of 76.1%. This underscores the sustainable demand for our products across the Food and cosmetics sectors, as well as the strength of our integrated value chain.

By the end of FY26, we boosted the capacity of our Solvent Fractionation Plant 2 (SF 2) by 30%, increasing it from 25,000 to 32,500 tonnes per annum through debottlenecking. We plan to implement similar capacity enhancements for Solvent Fractionation Plant 1 (SF 1), currently at 15,000 TPA.

As we look ahead, we aim to further strengthen our leadership position through planned strategic capex of approx INR 460 crores over the next 2–3 years. This includes investments in forward and backward integration, a new manufacturing facility for cocoa butter alternatives, refinery expansion and the establishment of a processing plant in Burkina Faso.

Manorama's net cash flow from operating activities stood at INR 259 Crores as on 31st March 2026. Our working capital cycle improved to approximately 125 days in FY26. Additionally, the Company's Board announced a final dividend of INR .80 paise (40% of face value of INR 2 per equity share) for financial year 2025-26."

Company Background

Manorama Industries is a Chhattisgarh-based manufacturer established in 2005, with its registered office in Mumbai, Maharashtra. The company has carved a niche in manufacturing Sal CBE & Stearin, Shea CBE & Stearin, Mango CBE & Stearin and other exotic fats & butters, offering customised solutions to companies in the chocolate, confectionery and cosmetic industries. The company holds multiple internationally recognised certifications, including ISO 9001, ISO 14001 & ISO 45001, and is certified for RSPO, Kosher, Halal (MUI), EcoVadis Committed Badge, and Sedex SMETA 4-Pillar. It is also a Government of India Recognized Star Export House and MSME ZED GOLD certified. The trading window, which was closed pursuant to the earlier intimation dated March 25, 2026, is set to reopen from Wednesday, May 13, 2026, following the 48-hour period post the declaration of financial results.